GlassScriptPhysician profile
Chanwit Roongsritong
NPI 1518956804
$2,680.51
in general payments reported to CMS, 2019-2025
14 companies · $191 in 2025
The $191 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $19.40 · 2021: $290 · 2022: $112 · 2023: $1,551 · 2024: $290 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,017 · Food and Beverage: $1,014.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,017.24 |
| Food and Beverage | $1,014.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $1,327.24 | 2023 | |
| Abiomed | $395.77 | 2019-2025 | Impella |
| Boston Scientific Corporation | $318.76 | 2023-2025 | Watchman Flx, Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit |
| Philips North America LLC | $180.56 | 2021-2022 | |
| Edwards Lifesciences Corporation | $125.48 | 2019 | |
| Recor Medical INC | $97.45 | 2025 | Paradise Ultrasound Renal Denervation System |
| Abbott Laboratories | $94.27 | 2021-2024 | Assurity |
| Actelion Pharmaceuticals US, INC. | $38.16 | 2023 | Uptravi, Opsumit |
| E.R. Squibb & Sons, L.L.C. | $37.89 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.80 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.52 | 2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $13.41 | 2019 | |
| Pfizer INC. | $12.20 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanwit Roongsritong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.